Improving access to hepatitis C care for urban, underserved patients using a primary care-based hepatitis C clinic

Journal of the National Medical Association

Volumn 104, Issue 5-6, 2012, Pages 244-250

  Miller, Lesley ^a   Fluker, Shelly Ann ^d   Osborn, Melissa ^a   Liu, Xiaoxia ^b   Strawder, Akilah ^c  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b GEORGIA STATE UNIVERSITY   (United States)

^c GRADY HEALTH SYSTEM   (United States)

^d NONE

Author keywords

African Americans; Hepatitis; Primary care; Underserved populations

Indexed keywords

ADULT; ANXIETY; ARTICLE; BIPOLAR DEPRESSION; COMORBIDITY; DEMOGRAPHY; DEPRESSION; DIABETES MELLITUS; FEASIBILITY STUDY; FEMALE; GENOTYPE; GEORGIA (REPUBLIC); HEALTH CARE ACCESS; HEPATITIS C; HUMAN; HYPERTENSION; LIVER CIRRHOSIS; LIVER FIBROSIS; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; PREVALENCE; PRIMARY MEDICAL CARE; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SUBSTANCE ABUSE; URBAN AREA; VIRUS LOAD; AFRICAN AMERICAN; CHI SQUARE DISTRIBUTION; HEALTH CARE DELIVERY; MIDDLE AGED; PATIENT; PRIMARY HEALTH CARE; STATISTICS; UNITED STATES; URBAN POPULATION; VIROLOGY;

AFRICAN AMERICANS; CHI-SQUARE DISTRIBUTION; COMORBIDITY; FEMALE; GENOTYPE; GEORGIA; HEALTH SERVICES ACCESSIBILITY; HEPATITIS C, CHRONIC; HUMANS; MALE; MEDICALLY UNINSURED; MIDDLE AGED; PRIMARY HEALTH CARE; RETROSPECTIVE STUDIES; URBAN POPULATION; VIRAL LOAD;

EID: 84865422792     PISSN: 00279684     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0027-9684(15)30161-9     Document Type: Article

References (24)

1. Armstrong GL, Wasley A, Simard EP, McQuillan GM, Kuhnert WL, Alter MJ. The prevalence of hepatitis C virus infection in the United States, 1999 through 2002. Ann Intern Med. 2006;144:705-714.
2. Pyrsopoulos N, Jeffers L. Hepatitis C in African Americans. J Clin Gastroenterol. 2007;41:185-193.
3. Fried MW, Shiffman ML, Reddy KR, et al. Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection. N Engl J Med. 2002;347:975-982.
4. Naffah F. Patients with hepatitis C are best managed by a specialist in liver diseases. CON: The management of hepatitis C in a community-based practice. Am J Gastroenterol. 2007;102:1839-1841.
5. McGinn TG, Gardenier D, McGinn LK, et al. Treating chronic hepatitis C in the primary care setting. Semin Liver Dis. 2005;25:65-71.
6. Shehab TM, Sonnad SS, Jeffries M, Gunaratnum N, Lok AS. Current practice patterns of primary care physicians in the management of patients with hepatitis C. Hepatology. 1999;30:794-800.
7. Yawn BP, Wollan P, Gazzuola L, Kim WR. Diagnosis and 10-year follow-up of a community-based hepatitis C cohort. J Fam Pract. 2002;51:135-140.
8. Clark EC, Yawn BP, Galliher JM, Temte JL, Hickner J. Hepatitis C identification and management by family physicians. Fam Med. 2005;37:644-649.
9. Bach PB, Pham HH, Schrag D, Tate RC, Hargraves JL. Primary care physicians who treat blacks and whites. N Engl J Med. 2004;351:575-584.
10. Alter MJ. Hepatitis C virus infection in the United States. J Hepatol. 1999;31(suppl 1):88-91.
11. National Institutes of Health Consensus Development Conference Statement: Management of hepatitis C 2002. Gastroenterology. 2002;123:2082-2099.
12. Colvin HM, Mitchell AE, eds. Hepatitis and Liver Cancer: A National Strategy for Prevention and Control of Hepatitis B and C. Washington, DC: The National Academies Press; 2010.
13. Ghany MG, Strader DB, Thomas DL, Seeff LB. Diagnosis, management, and treatment of hepatitis C: an update. Hepatology. 2009;49:1335-1374.
14. Pearlman BL. Hepatitis C virus infection in African Americans. Clin Infect Dis. 2006;42:82-91.
15. Reddy KR, Hoofnagle JH, Tong MJ, et al. Racial differences in responses to therapy with interferon in chronic hepatitis C. Consensus Interferon Study Group. Hepatology. 1999;30:787-793.
16. Conjeevaram HS, Fried MW, Jeffers LJ, et al. Peginterferon and ribavirin treatment in African American and Caucasian American patients with hepatitis C genotype 1. Gastroenterology. 2006;131:470-477.
17. Muir AJ, Bornstein JD, Killenberg PG. Peginterferon alfa-2b and ribavirin for the treatment of chronic hepatitis C in blacks and non-Hispanic whites. N Engl J Med. 2004;350:2265-2271.
18. Morrill JA, Shrestha M, Grant RW. Barriers to the treatment of hepatitis C. Patient, provider, and system factors. J Gen Intern Med. 2005;20:754-758.
19. Falck-Ytter Y, Kale H, Mullen KD, Sarbah SA, Sorescu L, McCullough AJ. Surprisingly small effect of antiviral treatment in patients with hepatitis C. Ann Intern Med. 2002;136:288-292.
20. Shehab TM, Orrego M, Chunduri R, Lok AS. Identification and management of hepatitis C patients in primary care clinics. Am J Gastroenterol. 2003;98:639-644.
21. Shehab TM, Sonnad SS, Lok AS. Management of hepatitis C patients by primary care physicians in the USA: results of a national survey. J Viral Hepat. 2001;8:377-383.
22. Cozzolongo R, Cuppone R, Petruzzi J, Stroffolini T, Manghisi OG. Approach of primary care physicians to hepatitis C: an educational survey from a Southern Italian area. J Infect. 2005;51:396-400.
23. Rocca LG, Yawn BP, Wollan P, Kim WR. Management of patients with hepatitis C in a community population: diagnosis, discussions, and decisions to treat. Ann Fam Med. 2004;2:116-124.
24. Davis GL, Alter MJ, El-Serag H, Poynard T, Jennings LW. Aging of hepatitis C virus (HCV)-infected persons in the United States: a multiple cohort model of HCV prevalence and disease progression. Gastroenterology. 2010;138:513-521.